Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGM2 | P21980 | 11/20 | 0.45 |
| ▸ | C3AR1 | Q16581 | 1/20 | 0.38 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.37 |
| ▸ | GNPAT | O15228 | 1/20 | 0.37 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.37 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.35 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.35 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7628303 | 1.00 | TGM2 (0.45) | TGM2C3AR1DDAH1GNPATFOLH1 | |
| SCHEMBL8177277 | 0.88 | C3AR1 (0.48) | TGM2C3AR1DDAH1GNPATFOLH1 | |
| SCHEMBL8177335 | 0.86 | TGM2 (0.55) | TGM2FOLH1ZDHHC20ZDHHC2 | |
| SCHEMBL28776336 | 0.86 | FOLH1 (0.38) | TGM2C3AR1FOLH1NOD1 | |
| SCHEMBL935421 | 0.86 | TGM2 (0.38) | TGM2C3AR1DDAH1ZDHHC20ZDHHC2 | |
| SCHEMBL28776339 | 0.86 | FOLH1 (0.38) | TGM2C3AR1FOLH1NOD1 | |
| SCHEMBL28883698 | 0.85 | NPY4R (0.42) | TGM2FOLH1ZDHHC20ZDHHC2 | |
| SCHEMBL28883697 | 0.85 | NPY4R (0.42) | TGM2FOLH1ZDHHC20ZDHHC2 | |
| SCHEMBL12971304 | 0.84 | C3AR1 (0.43) | C3AR1GNPATFOLH1NOD1 | |
| SCHEMBL29005731 | 0.84 | C3AR1 (0.43) | C3AR1GNPATFOLH1NOD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110684150-B | Amino acid nano hydrogel and preparation method and application thereof | 南方医科大学 | 2021-05-11 | — | — | CN | claimed |
| CN-110684150-A | Amino acid nano hydrogel and preparation method and application thereof | 南方医科大学 | 2020-01-14 | — | — | CN | claimed |
| US-20210388142-A1 | AMINO ACID-BASED POLYMERIZABLE COMPOUNDS AND OPHTHALMIC DEVICES PREPARED THEREFROM | JOHNSON & JOHNSON VISION CARE, INC. | 2021-12-16 | — | — | US | disclosed |
| CN-110684150-B | Amino acid nano hydrogel and preparation method and application thereof | 南方医科大学 | 2021-05-11 | — | — | CN | disclosed |
| CN-110684150-A | Amino acid nano hydrogel and preparation method and application thereof | 南方医科大学 | 2020-01-14 | — | — | CN | disclosed |
| US-10017461-B2 | Method of making ligand functionalized substrates | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2018-07-10 | — | — | US | disclosed |
| US-9650470-B2 | Method of making ligand functionalized substrates | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2017-05-16 | — | — | US | disclosed |
| US-20140364519-A1 | METHOD OF MAKING LIGAND FUNCTIONALIZED SUBSTRATES | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2014-12-11 | — | — | US | disclosed |
| US-8846203-B2 | Method of making ligand functionalized substrates | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2014-09-30 | — | — | US | disclosed |
| EP-2522692-B1 | Ligand monomers and copolymers made therewith | 3M INNOVATIVE PROPERTIES CO (US) | 2014-06-18 | — | — | EP | disclosed |
| US-20140087445-A1 | METHOD OF MAKING LIGAND FUNCTIONALIZED SUBSTRATES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2014-03-27 | — | — | US | disclosed |
| US-8652582-B2 | Method of making ligand functionalized substrates | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2014-02-18 | — | — | US | disclosed |
| EP-2522692-A1 | Ligand monomers and copolymers made therewith | 3M Innovative Properties Company (US) | 2012-11-14 | — | — | EP | disclosed |
| US-20110184078-A1 | Ligand Functionalized Substrates | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2011-07-28 | — | — | US | disclosed |
| US-20110033633-A1 | METHOD OF MAKING LIGAND FUNCTIONALIZED SUBSTRATES | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2011-02-10 | — | — | US | disclosed |
| US-6046289-A | FOR INHIBITING COAGULATION OF BLOOD PLATELETS, INHIBITING ADHESION OF ANIMAL CELLS, OR AS SUBSTRATE FOR CULTURING ANIMAL CELLS | FUJIFILM CORPORATION (JP) | 2000-04-04 | — | — | US | disclosed |
| EP-0488258-B1 | Propenamide derivatives, polymers, copolymers and use thereof | FUJI PHOTO FILM CO LTD (JP) | 1996-04-17 | — | — | EP | disclosed |
| EP-0488258-A2 | Propenamide derivatives, polymers, copolymers and use thereof | FUJI PHOTO FILM CO., LTD. (JP) | 1992-06-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10017461-B2 | Method of making ligand functionalized substrates | SPR, SELPLG, SIGLEC7 | TGM2 2172/4885C3AR1 1331/4885DDAH1 1482/4885 |
| US-20140364519-A1 | METHOD OF MAKING LIGAND FUNCTIONALIZED SUBSTRATES | SPR, SELPLG, SIGLEC7 | TGM2 2172/4885C3AR1 1331/4885DDAH1 1482/4885 |
| US-20110033633-A1 | METHOD OF MAKING LIGAND FUNCTIONALIZED SUBSTRATES | SPR, SELPLG, SIGLEC7 | TGM2 2172/4885C3AR1 1331/4885DDAH1 1482/4885 |
| US-20140087445-A1 | METHOD OF MAKING LIGAND FUNCTIONALIZED SUBSTRATES | SPR, SELPLG, SIGLEC7 | TGM2 2172/4885C3AR1 1331/4885DDAH1 1482/4885 |
| US-20210388142-A1 | AMINO ACID-BASED POLYMERIZABLE COMPOUNDS AND OPHTHALMIC DEVICES PREPARED THEREFROM | ARGLU1, BCAT2, BCAT1 | TGM2 137/4885C3AR1 950/4885DDAH1 594/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.